HealthCor Partners logo

HealthCor Partners

North America, South Carolina, United States, Charleston

Description

HealthCor Partners Management, L.P. (HealthCor Partners), is a registered investment advisor with the U.S. Securities and Exchange

Investor Profile

HealthCor Partners has made 20 investments, with 1 in the past 12 months and 10% as lead.

Stage Focus

  • Series Unknown (25%)
  • Series B (20%)
  • Series C (10%)
  • Post Ipo Equity (10%)
  • Series F (10%)
  • Series D (5%)
  • Seed (5%)
  • Post Ipo Debt (5%)
  • Series E (5%)
  • Convertible Note (5%)

Country Focus

  • United States (85%)
  • France (5%)
  • Canada (5%)
  • United Kingdom (5%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Health Diagnostics
  • Medical Device
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Oncology
  • Therapeutics
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does HealthCor Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 2
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 3
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 2
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 3
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Marshall Wace
Europe, England, United Kingdom, London
Co-Investments: 2
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 4
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 3

What are some of recent deals done by HealthCor Partners?

Heartflow

Mountain View, California, United States

Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical
Convertible NoteMar 26, 2025
Amount Raised: $98,000,000
HeartFlow

Mountain View, California, United States

HeartFlow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical
Series FApr 6, 2023
Amount Raised: $215,000,000
Karyopharm Therapeutics

Newton, Massachusetts, United States

Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.

Health CareMedicalPharmaceutical
Post Ipo EquityDec 5, 2022
Amount Raised: $165,000,000
Mineralys Therapeutics

Radnor, Pennsylvania, United States

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

BiopharmaBiotechnologyMedicalPharmaceutical
Series BJun 8, 2022
Amount Raised: $118,000,000
DNA Script

Le Kremlin-bicêtre, Ile-de-France, France

DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.

BiotechnologyHealth CareLife ScienceMedical
Series CJan 4, 2022
Amount Raised: $200,000,000
Acrivon Therapeutics

Cambridge, Massachusetts, United States

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

BiotechnologyHealth CareOncologyTherapeutics
Series BNov 11, 2021
Amount Raised: $100,000,000
Imperative Care

Campbell, California, United States

Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.

Health CareMedicalMedical Device
Series DJul 15, 2021
Amount Raised: $260,000,000
Ikena Oncology

Boston, Massachusetts, United States

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics
Series BJan 5, 2021
Amount Raised: $120,000,000
Claret Medical

Santa Rosa, California, United States

Claret Medical develops cerebral vascular protection systems for Transcatheter Aortic Valve Implantation (TAVI) and other procedures.

Health CareMedicalMedical Device
Series COct 23, 2017
Amount Raised: $14,500,000
PreemaTEX

Great River, New York, United States

PreemaTEX is a developer of diagnostic tests to assess a woman’s risk for preterm delivery early in pregnancy.

Health CareHealth Diagnostics
Series UnknownOct 1, 2015